Ramirez Asset Management, Inc. Grifols Sa Transaction History

Ramirez Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $51,602 - $63,371	-8,230 Reduced 13.58%	52,374 $330 Million
Q1 2024 May 14, 2024	BUY	$5.47 - $11.38 $69,698 - $145,003	12,742 Added 26.62%	60,604 $405 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $7,147 - $10,716	-927 Reduced 1.9%	47,862 $553 Million
Q3 2023 Nov 15, 2023	BUY	$8.91 - $10.91 $434,709 - $532,287	48,789 New	48,789 $446 Million

163

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.94B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Ramirez Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Ramirez Asset Management, Inc. with notifications on news.